日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic prediction for potato (Solanum tuberosum) quality traits improved through image analysis

通过图像分析改进马铃薯(Solanum tuberosum)品质性状的基因组预测

Yusuf, Muyideen; Miller, Michael D; Stefaniak, Thomas R; Haagenson, Darrin; Endelman, Jeffrey B; Thompson, Asunta L; Shannon, Laura M

ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report

ALVR109,一种现成的、部分HLA匹配的SARS-CoV-2特异性T细胞疗法,用于治疗心脏移植患者的难治性重症COVID-19肺炎:病例报告

Martits-Chalangari, Katalin; Spak, Cedric W; Askar, Medhat; Killian, Aaron; Fisher, Tammy L; Atillasoy, Ercem; Marshall, William L; McNeel, David; Miller, Michael D; Mathai, Susan K; Gottlieb, Robert L

HPV transcript expression affects cervical cancer response to chemoradiation

HPV 转录表达影响宫颈癌对放化疗的反应

Fiona J Ruiz, Matthew Inkman, Ramachandran Rashmi, Naoshad Muhammad, Nishanth Gabriel, Christopher A Miller, Michael D McLellan, Michael Goldstein, Stephanie Markovina, Perry W Grigsby, Jin Zhang, Julie K Schwarz

CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery

CD138 浆细胞可能预测切除和立体定向放射外科手术后的脑转移复发

Michael H Soike, Jennifer Logue, Shadi Qasem, Ryan T Hughes, Emory McTyre, Jing Su, Pierre Triozzi, Maurizio Bendandi, Hui-Wen Lo, Tamjeed Ahmed, Stacey S O'Neill, Waldemar Debinski, Boris Pasche, Kounosuke Watabe, Lance D Miller, Michael D Chan, Jimmy Ruiz

TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy

TLR7激动剂可诱导短暂性病毒血症,并减少接受抗逆转录病毒治疗的SIV感染恒河猴体内的病毒库。

Lim, So-Yon; Osuna, Christa E; Hraber, Peter T; Hesselgesser, Joe; Gerold, Jeffrey M; Barnes, Tiffany L; Sanisetty, Srisowmya; Seaman, Michael S; Lewis, Mark G; Geleziunas, Romas; Miller, Michael D; Cihlar, Tomas; Lee, William A; Hill, Alison L; Whitney, James B

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

索非布韦治疗后获得持续病毒学应答的患者中,晚期复发与丙型肝炎病毒再感染的比较

Sarrazin, Christoph; Isakov, Vasily; Svarovskaia, Evguenia S; Hedskog, Charlotte; Martin, Ross; Chodavarapu, Krishna; Brainard, Diana M; Miller, Michael D; Mo, Hongmei; Molina, Jean-Michel; Sulkowski, Mark S

Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128)

在 HIV-1 感染女性中,Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF 与 Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF 的第 48 周耐药性分析(WAVES 研究 GS-US-236-0128)

Kulkarni, Rima; Hodder, Sally L; Cao, Huyen; Chang, Silvia; Miller, Michael D; White, Kirsten L

Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6

对感染丙型肝炎病毒5型和6型基因型患者的NS3/4A、NS5A和NS5B基因进行测序分析

Ku, Karin S; Chodavarapu, Ramakrishna K; Martin, Ross; Miller, Michael D; Mo, Hongmei; Svarovskaia, Evguenia S

Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions

HIV-1 整合酶链转移抑制剂耐药突变 Q148R 或 N155H 与核苷/核苷酸逆转录酶抑制剂耐药突变组合的药物敏感性和病毒适应性

Andreatta, Kristen N; Miller, Michael D; White, Kirsten L

Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations

多拉韦林在临床相关浓度下可抑制常见非核苷类逆转录酶抑制剂相关突变体

Feng, Meizhen; Sachs, Nancy A; Xu, Min; Grobler, Jay; Blair, Wade; Hazuda, Daria J; Miller, Michael D; Lai, Ming-Tain